Mayo Clinic in Florida

Running trials

• Not yet recruiting

  Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida

  NCT06607874· Source

• Not yet recruiting

  Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

  NCT07281547· Phase 4· Source

• Not yet recruiting

  A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS)

  NCT07906665· Phase 1· Source

• Not yet recruiting

  A Study of the Effect of a Nurse Navigator Program on High Risk Patients

  NCT05592847· Source

• Recruiting

  Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

  NCT06770023· Phase 1· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Source

• Not yet recruiting

  Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors

  NCT07769047· Phase 4· Source

• Recruiting

  Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma

  NCT07708961· Phase 2· Source

• Recruiting

  Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

  NCT07805954· Phase 3· Source

• Recruiting

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· Phase 3· Source

• Enrolling by invitation

  Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

  NCT05408728· Source

• Recruiting

  Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

  NCT07545837· Source

• Recruiting

  A Phase 1 Study of the Safety and Tolerability of CTX-10726

  NCT07419841· Phase 1· Source

• Recruiting

  Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

  NCT07621718· Phase 3· Source

• Recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  NCT07589595· Phase 2· Source

• Recruiting

  A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men

  NCT07126548· Source

• Recruiting

  Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

  NCT07618273· Source

• Recruiting

  The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

  NCT07218445· Phase 4· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

  NCT07221149· Phase 2/3· Source

• Recruiting

  A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  NCT07450859· Phase 2· Source

• Recruiting

  A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  NCT07277413· Phase 1· Source

• Recruiting

  Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

  NCT06900595· Phase 2· Source

• Recruiting

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· Phase 2· Source

• Recruiting

  Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

  NCT06997094· Phase 1· Source

• Recruiting

  Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

  NCT07073794· Phase 2· Source

• Recruiting

  Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

  NCT07096778· Phase 2· Source

• Recruiting

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  NCT07321106· Phase 1· Source

• Recruiting

  A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  NCT07188558· Phase 3· Source

• Recruiting

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· Phase 2/3· Source

• Recruiting

  Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

  NCT07110454· Source

• Recruiting

  Diagnosing Epilepsy To EffeCT Change

  NCT07110337· Source

• Recruiting

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· Phase 3· Source

• Recruiting

  Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

  NCT07287397· Phase 1/2· Source

• Recruiting

  The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

  NCT07285044· Phase 2· Source

• Recruiting

  A Long-term Follow-up Study in Patients Who Received BEAM-101

  NCT07373639· Source

• Recruiting

  BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

  NCT07226856· Phase 2· Source

• Recruiting

  Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

  NCT07311993· Phase 1· Source

• Recruiting

  Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  NCT07061964· Phase 2· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

  NCT06948448· Phase 2· Source

• Active, not recruiting

  A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

  NCT07076121· Phase 2/3· Source

• Recruiting

  A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

  NCT07227532· Source

• Recruiting

  A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  NCT07008118· Phase 1· Source

• Recruiting

  A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  NCT07175038· Phase 2· Source

• Recruiting

  A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

  NCT07074756· Source

• Recruiting

  Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

  NCT06940271· Source

• Active, not recruiting

  A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

  NCT06985147· Phase 2· Source

• Recruiting

  Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

  NCT07091864· Source

• Recruiting

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· Phase 2/3· Source

• Recruiting

  Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  NCT07000084· Phase 3· Source

• Recruiting

  A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  NCT06997497· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer18 recruiting
• Childhood cancers13 recruiting
• Colorectal cancer13 recruiting
• Pancreatic cancer13 recruiting
• Melanoma12 recruiting
• Multiple myeloma12 recruiting
• Prostate cancer12 recruiting
• Bladder cancer11 recruiting
• Ovarian cancer10 recruiting
• Endometrial cancer9 recruiting
• Liver and biliary tract cancer9 recruiting
• Glioblastoma8 recruiting
• Head and neck cancer8 recruiting
• Kidney cancer8 recruiting
• Sarcoma8 recruiting
• ALS (motor neurone disease)7 recruiting
• Gastric and esophageal cancer7 recruiting
• Metastatic breast cancer7 recruiting
• Epilepsy6 recruiting
• Myelodysplastic syndromes6 recruiting
• Neuroendocrine tumours6 recruiting
• Acute myeloid leukemia5 recruiting
• Cervical cancer5 recruiting
• Obesity5 recruiting
• Triple-negative breast cancer5 recruiting
• High blood pressure4 recruiting
• Chronic kidney disease3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Follicular lymphoma3 recruiting
• Heart failure3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Alzheimer disease2 recruiting
• HIV2 recruiting
• Mantle cell lymphoma2 recruiting
• Mesothelioma2 recruiting
• Thyroid cancer2 recruiting
• Amyloidosis1 recruiting
• Atrial fibrillation1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Frontotemporal dementia1 recruiting
• Hodgkin lymphoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• IgA nephropathy1 recruiting
• Lewy body dementia1 recruiting
• Migraine1 recruiting
• Myasthenia gravis1 recruiting
• Parkinson disease1 recruiting
• Sickle cell disease1 recruiting
• Stroke1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings

  NCT06960057· Source

• Terminated

  Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06790966· Phase 3· Source

• Completed

  InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors

  NCT06703996· Source

• Terminated

  Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

  NCT05554354· Phase 2· Source

• Completed

  Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)

  NCT06470750· Source

• Completed

  Anti-Diabetic Medications to Fight PD and LBD

  NCT06263673· Phase 4· Source

• Completed

  Extracellular Vesicle Cargo in Obesity and Type 2 Diabetes

  NCT06401876· Source

• Completed

  Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

  NCT05730712· Phase 2· Source

• Terminated

  CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

  NCT05689021· Phase 2· Source

• Completed

  Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT06058793· Phase 3· Source

• Terminated

  Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

  NCT05712694· Phase 3· Source

• Completed

  iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men

  NCT06535802· Source

• Completed

  A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

  NCT06151717· Source

• Completed

  Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

  NCT06037863· Source

• Terminated

  Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

  NCT05580588· Phase 2· Source

• Completed

  Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning

  NCT05979883· Source

• Terminated

  Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

  NCT04975516· Phase 2· Source

• Completed

  Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

  NCT05557162· Source

• Terminated

  Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules

  NCT05556525· Source

• Completed

  A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

  NCT05559580· Phase 2· Source

• Terminated

  Oral AMXT 1501 Dicaprate in Combination With IV DFMO

  NCT05500508· Phase 1/2· Source

• Completed

  An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

  NCT05560009· Source

• Terminated

  E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic Melanoma

  NCT05388877· Phase 1· Source

• Terminated

  Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

  NCT05393713· Phase 1· Source

• Completed

  A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

  NCT05521191· Phase 1· Source

• Completed

  A Drug-drug Interaction Study of Avapritinib and Midazolam

  NCT04908176· Phase 1· Source

• Completed

  Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)

  NCT05446870· Phase 2· Source

• Completed

  Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

  NCT05854992· Source

• Completed

  Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease

  NCT05362786· Phase 1· Source

• Terminated

  Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

  NCT05288062· Phase 2· Source

• Recruiting

  Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

  NCT05168163· Phase 2· Source

• Terminated

  Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder

  NCT05307770· Source

• Terminated

  A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

  NCT05242822· Phase 1· Source

• Completed

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· Phase 3· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· Phase 3· Source

• Completed

  Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

  NCT05104853· Phase 1/2· Source

• Recruiting

  A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  NCT04929223· Phase 1· Source

• Completed

  Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

  NCT05024045· Phase 1· Source

• Completed

  Improving Wellbeing in Ischemic Heart Disease

  NCT04974541· Source

• Terminated

  Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

  NCT04588246· Phase 3· Source

• Terminated

  Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

  NCT04778397· Phase 3· Source

• Terminated

  A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

  NCT04996004· Phase 2· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· Phase 3· Source

• Completed

  Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer

  NCT04493060· Phase 2· Source

• Terminated

  Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study

  NCT04230304· Phase 2· Source

• Terminated

  Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer

  NCT04396535· Phase 2· Source

• Terminated

  A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

  NCT04494256· Phase 1/2· Source

• Completed

  Molecular Mechanisms of Exercise Benefits to Insulin Resistant People

  NCT04158375· Source

• Completed

  A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer

  NCT04322539· Phase 3· Source

• Terminated

  Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

  NCT04517838· Source

Trial sites

• Mayo Clinic Florida107 trials
• Mayo Clinic Florida, Jacksonville1 trial
• Mayo Clinic Florida (Site 0024)1 trial
• Mayo Clinic Florida (Site 0115)1 trial
• Mayo Clinic Florida (Site #0148)1 trial
• Mayo Clinic Florida (Site 4043)1 trial
• Mayo Clinic in Florida270 trials
• Mayo Clinic in Florida (Site 0014)1 trial
• Mayo Clinic in Florida (Site 0092)1 trial
• Mayo Clinic in Florida (Site 0101)1 trial
• Mayo Clinic in Florida - Site #3211 trial
• Mayo Clinic in Florida- Site Number : 84000021 trial
• Mayo Clinic in Florida- Site Number : 84000031 trial
• Mayo Clinic in Florida- Site Number : 84000081 trial
• Mayo Clinic in Florida- Site Number : 84010931 trial
• Mayo Clinic Jacksonville Florida1 trial
• Mayo Clinic of Florida1 trial
• Mayo Clinic of Jacksonville Florida1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease209 works · 4 trials
• Heart failure101 works · 5 trials
• Prostate cancer60 works · 28 trials
• Melanoma57 works · 29 trials
• Multiple myeloma55 works · 28 trials
• Chronic kidney disease46 works · 5 trials
• Pancreatic cancer46 works · 23 trials
• Epilepsy42 works · 7 trials
• Glioblastoma41 works · 21 trials
• Acute myeloid leukemia37 works · 11 trials
• Glaucoma35 works · 0 trials
• Hodgkin lymphoma33 works · 1 trials
• Frontotemporal dementia30 works · 2 trials
• Sarcoma30 works · 22 trials
• ALS (motor neurone disease)29 works · 11 trials
• Neuroendocrine tumours27 works · 12 trials
• Diffuse large B-cell lymphoma26 works · 5 trials
• Kidney cancer26 works · 11 trials
• Triple-negative breast cancer26 works · 11 trials
• Crohn's disease26 works · 2 trials
• Ulcerative colitis24 works · 0 trials
• Amyloidosis21 works · 2 trials
• Chronic lymphocytic leukaemia20 works · 6 trials
• Myelodysplastic syndromes19 works · 13 trials
• Metastatic breast cancer19 works · 24 trials
• Polycystic kidney disease16 works · 1 trials
• Lewy body dementia14 works · 2 trials
• Myeloproliferative neoplasms14 works · 6 trials
• Mantle cell lymphoma11 works · 6 trials
• Follicular lymphoma10 works · 6 trials